Entering text into the input field will update the search result below

Pfizer-BioNTech's COVID-19 vaccine shows 100% efficacy in long-term analysis in adolescents

Covid-19 Vaccine

carmengabriela/iStock Editorial via Getty Images

  • Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) announce topline results from a longer-term analysis of the safety and efficacy of their COVID-19 vaccine in individuals 12 through 15 years of age.
  • The updated findings from Phase

Recommended For You

Related Stocks

SymbolLast Price% Chg
PFE
--
BNTX
--